nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—atherosclerosis	0.286	1	CbGaD
Ceftriaxone—SLC22A11—Pravastatin—atherosclerosis	0.213	0.423	CbGbCtD
Ceftriaxone—SLC22A8—Pravastatin—atherosclerosis	0.124	0.246	CbGbCtD
Ceftriaxone—SLC22A6—Pravastatin—atherosclerosis	0.0864	0.171	CbGbCtD
Ceftriaxone—ALB—Rosuvastatin—atherosclerosis	0.0809	0.16	CbGbCtD
Ceftriaxone—Warmth—Niacin—atherosclerosis	0.0042	0.0289	CcSEcCtD
Ceftriaxone—Cholelithiasis—Ezetimibe—atherosclerosis	0.00245	0.0169	CcSEcCtD
Ceftriaxone—Cholelithiasis—Niacin—atherosclerosis	0.00215	0.0148	CcSEcCtD
Ceftriaxone—Proteinuria—Rosuvastatin—atherosclerosis	0.00209	0.0144	CcSEcCtD
Ceftriaxone—Laryngeal oedema—Niacin—atherosclerosis	0.00208	0.0143	CcSEcCtD
Ceftriaxone—Protein urine present—Rosuvastatin—atherosclerosis	0.00206	0.0142	CcSEcCtD
Ceftriaxone—Drug interaction—Rosuvastatin—atherosclerosis	0.00198	0.0136	CcSEcCtD
Ceftriaxone—Tenderness—Lovastatin—atherosclerosis	0.00178	0.0123	CcSEcCtD
Ceftriaxone—Cholestasis—Niacin—atherosclerosis	0.00176	0.0121	CcSEcCtD
Ceftriaxone—Feeling hot—Niacin—atherosclerosis	0.0017	0.0117	CcSEcCtD
Ceftriaxone—Tenderness—Simvastatin—atherosclerosis	0.00167	0.0115	CcSEcCtD
Ceftriaxone—Proteinuria—Simvastatin—atherosclerosis	0.00165	0.0114	CcSEcCtD
Ceftriaxone—Drug interaction—Ezetimibe—atherosclerosis	0.00164	0.0113	CcSEcCtD
Ceftriaxone—Protein urine present—Simvastatin—atherosclerosis	0.00163	0.0112	CcSEcCtD
Ceftriaxone—Hypertonia—Rosuvastatin—atherosclerosis	0.00161	0.0111	CcSEcCtD
Ceftriaxone—Drug interaction—Simvastatin—atherosclerosis	0.00157	0.0108	CcSEcCtD
Ceftriaxone—Cefazolin—PON1—atherosclerosis	0.00153	0.393	CrCbGaD
Ceftriaxone—Tenderness—Pravastatin—atherosclerosis	0.00151	0.0104	CcSEcCtD
Ceftriaxone—Drug interaction—Pravastatin—atherosclerosis	0.00142	0.00977	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Niacin—atherosclerosis	0.00133	0.0092	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00129	0.0089	CcSEcCtD
Ceftriaxone—Vaginal infection—Niacin—atherosclerosis	0.00126	0.00869	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00125	0.00861	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00121	0.00832	CcSEcCtD
Ceftriaxone—Hypertonia—Niacin—atherosclerosis	0.00117	0.00806	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00117	0.00806	CcSEcCtD
Ceftriaxone—Pancreatitis—Rosuvastatin—atherosclerosis	0.00113	0.00778	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Niacin—atherosclerosis	0.00111	0.00764	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00109	0.00752	CcSEcCtD
Ceftriaxone—Haemolytic anaemia—Pravastatin—atherosclerosis	0.00106	0.00728	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00102	0.007	CcSEcCtD
Ceftriaxone—Jaundice—Rosuvastatin—atherosclerosis	0.001	0.00689	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000996	0.00687	CcSEcCtD
Ceftriaxone—Haematuria—Rosuvastatin—atherosclerosis	0.000978	0.00674	CcSEcCtD
Ceftriaxone—Eosinophilia—Lovastatin—atherosclerosis	0.000965	0.00665	CcSEcCtD
Ceftriaxone—Pancreatitis—Lovastatin—atherosclerosis	0.000956	0.00659	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00095	0.00655	CcSEcCtD
Ceftriaxone—Eosinophilia—Ezetimibe—atherosclerosis	0.000947	0.00653	CcSEcCtD
Ceftriaxone—Pancreatitis—Ezetimibe—atherosclerosis	0.000937	0.00646	CcSEcCtD
Ceftriaxone—Eosinophilia—Simvastatin—atherosclerosis	0.000903	0.00622	CcSEcCtD
Ceftriaxone—Pancreatitis—Simvastatin—atherosclerosis	0.000894	0.00616	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000862	0.00594	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000859	0.00592	CcSEcCtD
Ceftriaxone—Jaundice—Ezetimibe—atherosclerosis	0.000831	0.00573	CcSEcCtD
Ceftriaxone—Eosinophilia—Pravastatin—atherosclerosis	0.000816	0.00563	CcSEcCtD
Ceftriaxone—Pancreatitis—Pravastatin—atherosclerosis	0.000808	0.00557	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000806	0.00556	CcSEcCtD
Ceftriaxone—Sweating increased—Pravastatin—atherosclerosis	0.000803	0.00554	CcSEcCtD
Ceftriaxone—Jaundice—Simvastatin—atherosclerosis	0.000792	0.00546	CcSEcCtD
Ceftriaxone—Flatulence—Rosuvastatin—atherosclerosis	0.00079	0.00545	CcSEcCtD
Ceftriaxone—Erythema multiforme—Lovastatin—atherosclerosis	0.000738	0.00509	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000729	0.00502	CcSEcCtD
Ceftriaxone—Jaundice—Niacin—atherosclerosis	0.000728	0.00502	CcSEcCtD
Ceftriaxone—Stomatitis—Niacin—atherosclerosis	0.000728	0.00502	CcSEcCtD
Ceftriaxone—Flushing—Lovastatin—atherosclerosis	0.000724	0.00499	CcSEcCtD
Ceftriaxone—Erythema multiforme—Ezetimibe—atherosclerosis	0.000723	0.00499	CcSEcCtD
Ceftriaxone—Jaundice—Pravastatin—atherosclerosis	0.000716	0.00494	CcSEcCtD
Ceftriaxone—Flushing—Ezetimibe—atherosclerosis	0.00071	0.0049	CcSEcCtD
Ceftriaxone—Chills—Lovastatin—atherosclerosis	0.0007	0.00483	CcSEcCtD
Ceftriaxone—Erythema multiforme—Simvastatin—atherosclerosis	0.00069	0.00476	CcSEcCtD
Ceftriaxone—Flushing—Simvastatin—atherosclerosis	0.000677	0.00467	CcSEcCtD
Ceftriaxone—Haemoglobin—Niacin—atherosclerosis	0.000673	0.00464	CcSEcCtD
Ceftriaxone—Haemorrhage—Niacin—atherosclerosis	0.00067	0.00462	CcSEcCtD
Ceftriaxone—Flatulence—Lovastatin—atherosclerosis	0.000669	0.00461	CcSEcCtD
Ceftriaxone—Dysgeusia—Lovastatin—atherosclerosis	0.000665	0.00459	CcSEcCtD
Ceftriaxone—Flatulence—Ezetimibe—atherosclerosis	0.000656	0.00453	CcSEcCtD
Ceftriaxone—Chills—Simvastatin—atherosclerosis	0.000655	0.00452	CcSEcCtD
Ceftriaxone—Infection—Rosuvastatin—atherosclerosis	0.00065	0.00448	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00064	0.00442	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Lovastatin—atherosclerosis	0.00063	0.00435	CcSEcCtD
Ceftriaxone—Flatulence—Simvastatin—atherosclerosis	0.000626	0.00432	CcSEcCtD
Ceftriaxone—Cefdinir—MPO—atherosclerosis	0.000625	0.161	CrCbGaD
Ceftriaxone—Erythema multiforme—Pravastatin—atherosclerosis	0.000624	0.0043	CcSEcCtD
Ceftriaxone—Dysgeusia—Simvastatin—atherosclerosis	0.000622	0.00429	CcSEcCtD
Ceftriaxone—Flushing—Niacin—atherosclerosis	0.000622	0.00429	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000618	0.00426	CcSEcCtD
Ceftriaxone—Anaemia—Ezetimibe—atherosclerosis	0.000616	0.00425	CcSEcCtD
Ceftriaxone—Malaise—Lovastatin—atherosclerosis	0.000612	0.00422	CcSEcCtD
Ceftriaxone—Flushing—Pravastatin—atherosclerosis	0.000612	0.00422	CcSEcCtD
Ceftriaxone—Leukopenia—Lovastatin—atherosclerosis	0.000608	0.00419	CcSEcCtD
Ceftriaxone—Chills—Niacin—atherosclerosis	0.000601	0.00415	CcSEcCtD
Ceftriaxone—Malaise—Ezetimibe—atherosclerosis	0.000601	0.00414	CcSEcCtD
Ceftriaxone—Chills—Pravastatin—atherosclerosis	0.000592	0.00408	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000589	0.00406	CcSEcCtD
Ceftriaxone—Palpitations—Ezetimibe—atherosclerosis	0.000589	0.00406	CcSEcCtD
Ceftriaxone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000587	0.00405	CcSEcCtD
Ceftriaxone—Anaemia—Simvastatin—atherosclerosis	0.000587	0.00405	CcSEcCtD
Ceftriaxone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000576	0.00397	CcSEcCtD
Ceftriaxone—Flatulence—Niacin—atherosclerosis	0.000575	0.00396	CcSEcCtD
Ceftriaxone—Malaise—Simvastatin—atherosclerosis	0.000573	0.00395	CcSEcCtD
Ceftriaxone—Discomfort—Lovastatin—atherosclerosis	0.000571	0.00394	CcSEcCtD
Ceftriaxone—Leukopenia—Simvastatin—atherosclerosis	0.000569	0.00392	CcSEcCtD
Ceftriaxone—Flatulence—Pravastatin—atherosclerosis	0.000566	0.0039	CcSEcCtD
Ceftriaxone—Dysgeusia—Pravastatin—atherosclerosis	0.000562	0.00388	CcSEcCtD
Ceftriaxone—Discomfort—Ezetimibe—atherosclerosis	0.00056	0.00386	CcSEcCtD
Ceftriaxone—Pain—Rosuvastatin—atherosclerosis	0.000559	0.00386	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000554	0.00382	CcSEcCtD
Ceftriaxone—Infection—Lovastatin—atherosclerosis	0.000551	0.0038	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000544	0.00375	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000543	0.00374	CcSEcCtD
Ceftriaxone—Infection—Ezetimibe—atherosclerosis	0.00054	0.00372	CcSEcCtD
Ceftriaxone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000539	0.00372	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000535	0.00369	CcSEcCtD
Ceftriaxone—Discomfort—Simvastatin—atherosclerosis	0.000534	0.00368	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000533	0.00367	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000532	0.00367	CcSEcCtD
Ceftriaxone—Anaemia—Pravastatin—atherosclerosis	0.000531	0.00366	CcSEcCtD
Ceftriaxone—Leukopenia—Niacin—atherosclerosis	0.000522	0.0036	CcSEcCtD
Ceftriaxone—Urticaria—Rosuvastatin—atherosclerosis	0.00052	0.00358	CcSEcCtD
Ceftriaxone—Oedema—Simvastatin—atherosclerosis	0.000518	0.00357	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000518	0.00357	CcSEcCtD
Ceftriaxone—Malaise—Pravastatin—atherosclerosis	0.000518	0.00357	CcSEcCtD
Ceftriaxone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000517	0.00357	CcSEcCtD
Ceftriaxone—Palpitations—Niacin—atherosclerosis	0.000515	0.00355	CcSEcCtD
Ceftriaxone—Infection—Simvastatin—atherosclerosis	0.000515	0.00355	CcSEcCtD
Ceftriaxone—Leukopenia—Pravastatin—atherosclerosis	0.000514	0.00354	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000508	0.0035	CcSEcCtD
Ceftriaxone—Paraesthesia—Lovastatin—atherosclerosis	0.000498	0.00343	CcSEcCtD
Ceftriaxone—Paraesthesia—Ezetimibe—atherosclerosis	0.000488	0.00337	CcSEcCtD
Ceftriaxone—Dyspepsia—Lovastatin—atherosclerosis	0.000488	0.00336	CcSEcCtD
Ceftriaxone—Discomfort—Pravastatin—atherosclerosis	0.000483	0.00333	CcSEcCtD
Ceftriaxone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000482	0.00332	CcSEcCtD
Ceftriaxone—Dyspepsia—Ezetimibe—atherosclerosis	0.000479	0.0033	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Niacin—atherosclerosis	0.000476	0.00328	CcSEcCtD
Ceftriaxone—Oedema—Niacin—atherosclerosis	0.000476	0.00328	CcSEcCtD
Ceftriaxone—Pain—Lovastatin—atherosclerosis	0.000474	0.00327	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000469	0.00323	CcSEcCtD
Ceftriaxone—Oedema—Pravastatin—atherosclerosis	0.000469	0.00323	CcSEcCtD
Ceftriaxone—Infection—Pravastatin—atherosclerosis	0.000466	0.00321	CcSEcCtD
Ceftriaxone—Paraesthesia—Simvastatin—atherosclerosis	0.000466	0.00321	CcSEcCtD
Ceftriaxone—Pain—Ezetimibe—atherosclerosis	0.000465	0.00321	CcSEcCtD
Ceftriaxone—Cefotetan—ALB—atherosclerosis	0.000463	0.119	CrCbGaD
Ceftriaxone—Pruritus—Rosuvastatin—atherosclerosis	0.000463	0.00319	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Niacin—atherosclerosis	0.00046	0.00317	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000459	0.00316	CcSEcCtD
Ceftriaxone—Feeling abnormal—Lovastatin—atherosclerosis	0.000457	0.00315	CcSEcCtD
Ceftriaxone—Dyspepsia—Simvastatin—atherosclerosis	0.000456	0.00315	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000453	0.00313	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000453	0.00312	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000448	0.00309	CcSEcCtD
Ceftriaxone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000447	0.00309	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000445	0.00307	CcSEcCtD
Ceftriaxone—Pain—Simvastatin—atherosclerosis	0.000443	0.00306	CcSEcCtD
Ceftriaxone—Urticaria—Lovastatin—atherosclerosis	0.00044	0.00304	CcSEcCtD
Ceftriaxone—Abdominal pain—Lovastatin—atherosclerosis	0.000438	0.00302	CcSEcCtD
Ceftriaxone—Body temperature increased—Lovastatin—atherosclerosis	0.000438	0.00302	CcSEcCtD
Ceftriaxone—Dizziness—Rosuvastatin—atherosclerosis	0.000432	0.00298	CcSEcCtD
Ceftriaxone—Urticaria—Ezetimibe—atherosclerosis	0.000432	0.00298	CcSEcCtD
Ceftriaxone—Abdominal pain—Ezetimibe—atherosclerosis	0.00043	0.00296	CcSEcCtD
Ceftriaxone—Body temperature increased—Ezetimibe—atherosclerosis	0.00043	0.00296	CcSEcCtD
Ceftriaxone—Paraesthesia—Niacin—atherosclerosis	0.000427	0.00295	CcSEcCtD
Ceftriaxone—Feeling abnormal—Simvastatin—atherosclerosis	0.000427	0.00295	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000424	0.00292	CcSEcCtD
Ceftriaxone—Paraesthesia—Pravastatin—atherosclerosis	0.000421	0.0029	CcSEcCtD
Ceftriaxone—Dyspepsia—Niacin—atherosclerosis	0.000419	0.00289	CcSEcCtD
Ceftriaxone—Dyspepsia—Pravastatin—atherosclerosis	0.000413	0.00285	CcSEcCtD
Ceftriaxone—Rash—Rosuvastatin—atherosclerosis	0.000412	0.00284	CcSEcCtD
Ceftriaxone—Dermatitis—Rosuvastatin—atherosclerosis	0.000412	0.00284	CcSEcCtD
Ceftriaxone—Urticaria—Simvastatin—atherosclerosis	0.000412	0.00284	CcSEcCtD
Ceftriaxone—Abdominal pain—Simvastatin—atherosclerosis	0.00041	0.00283	CcSEcCtD
Ceftriaxone—Body temperature increased—Simvastatin—atherosclerosis	0.00041	0.00283	CcSEcCtD
Ceftriaxone—Headache—Rosuvastatin—atherosclerosis	0.00041	0.00283	CcSEcCtD
Ceftriaxone—Hypersensitivity—Lovastatin—atherosclerosis	0.000408	0.00282	CcSEcCtD
Ceftriaxone—Pain—Niacin—atherosclerosis	0.000407	0.00281	CcSEcCtD
Ceftriaxone—Cefpiramide—ALB—atherosclerosis	0.000403	0.104	CrCbGaD
Ceftriaxone—Pain—Pravastatin—atherosclerosis	0.000401	0.00276	CcSEcCtD
Ceftriaxone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000401	0.00276	CcSEcCtD
Ceftriaxone—Pruritus—Lovastatin—atherosclerosis	0.000392	0.0027	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Niacin—atherosclerosis	0.000389	0.00268	CcSEcCtD
Ceftriaxone—Nausea—Rosuvastatin—atherosclerosis	0.000388	0.00268	CcSEcCtD
Ceftriaxone—Feeling abnormal—Pravastatin—atherosclerosis	0.000386	0.00266	CcSEcCtD
Ceftriaxone—Pruritus—Ezetimibe—atherosclerosis	0.000385	0.00265	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000383	0.00264	CcSEcCtD
Ceftriaxone—Hypersensitivity—Simvastatin—atherosclerosis	0.000382	0.00263	CcSEcCtD
Ceftriaxone—Diarrhoea—Lovastatin—atherosclerosis	0.000379	0.00262	CcSEcCtD
Ceftriaxone—Urticaria—Niacin—atherosclerosis	0.000378	0.00261	CcSEcCtD
Ceftriaxone—Body temperature increased—Niacin—atherosclerosis	0.000376	0.00259	CcSEcCtD
Ceftriaxone—Abdominal pain—Niacin—atherosclerosis	0.000376	0.00259	CcSEcCtD
Ceftriaxone—Urticaria—Pravastatin—atherosclerosis	0.000372	0.00257	CcSEcCtD
Ceftriaxone—Diarrhoea—Ezetimibe—atherosclerosis	0.000372	0.00256	CcSEcCtD
Ceftriaxone—Abdominal pain—Pravastatin—atherosclerosis	0.000371	0.00256	CcSEcCtD
Ceftriaxone—Body temperature increased—Pravastatin—atherosclerosis	0.000371	0.00256	CcSEcCtD
Ceftriaxone—Pruritus—Simvastatin—atherosclerosis	0.000367	0.00253	CcSEcCtD
Ceftriaxone—Dizziness—Lovastatin—atherosclerosis	0.000367	0.00253	CcSEcCtD
Ceftriaxone—Dizziness—Ezetimibe—atherosclerosis	0.000359	0.00248	CcSEcCtD
Ceftriaxone—Diarrhoea—Simvastatin—atherosclerosis	0.000355	0.00245	CcSEcCtD
Ceftriaxone—Vomiting—Lovastatin—atherosclerosis	0.000352	0.00243	CcSEcCtD
Ceftriaxone—Cefonicid—ALB—atherosclerosis	0.000351	0.0903	CrCbGaD
Ceftriaxone—Hypersensitivity—Niacin—atherosclerosis	0.000351	0.00242	CcSEcCtD
Ceftriaxone—Rash—Lovastatin—atherosclerosis	0.000349	0.00241	CcSEcCtD
Ceftriaxone—Dermatitis—Lovastatin—atherosclerosis	0.000349	0.00241	CcSEcCtD
Ceftriaxone—Headache—Lovastatin—atherosclerosis	0.000347	0.00239	CcSEcCtD
Ceftriaxone—Vomiting—Ezetimibe—atherosclerosis	0.000346	0.00238	CcSEcCtD
Ceftriaxone—Hypersensitivity—Pravastatin—atherosclerosis	0.000345	0.00238	CcSEcCtD
Ceftriaxone—Dizziness—Simvastatin—atherosclerosis	0.000343	0.00236	CcSEcCtD
Ceftriaxone—Rash—Ezetimibe—atherosclerosis	0.000343	0.00236	CcSEcCtD
Ceftriaxone—Dermatitis—Ezetimibe—atherosclerosis	0.000342	0.00236	CcSEcCtD
Ceftriaxone—Headache—Ezetimibe—atherosclerosis	0.000341	0.00235	CcSEcCtD
Ceftriaxone—Pruritus—Niacin—atherosclerosis	0.000337	0.00232	CcSEcCtD
Ceftriaxone—Pruritus—Pravastatin—atherosclerosis	0.000332	0.00229	CcSEcCtD
Ceftriaxone—Vomiting—Simvastatin—atherosclerosis	0.00033	0.00227	CcSEcCtD
Ceftriaxone—Nausea—Lovastatin—atherosclerosis	0.000329	0.00227	CcSEcCtD
Ceftriaxone—Rash—Simvastatin—atherosclerosis	0.000327	0.00225	CcSEcCtD
Ceftriaxone—Dermatitis—Simvastatin—atherosclerosis	0.000327	0.00225	CcSEcCtD
Ceftriaxone—Diarrhoea—Niacin—atherosclerosis	0.000326	0.00225	CcSEcCtD
Ceftriaxone—Headache—Simvastatin—atherosclerosis	0.000325	0.00224	CcSEcCtD
Ceftriaxone—Nausea—Ezetimibe—atherosclerosis	0.000323	0.00223	CcSEcCtD
Ceftriaxone—Diarrhoea—Pravastatin—atherosclerosis	0.000321	0.00221	CcSEcCtD
Ceftriaxone—Dizziness—Niacin—atherosclerosis	0.000315	0.00217	CcSEcCtD
Ceftriaxone—Dizziness—Pravastatin—atherosclerosis	0.00031	0.00214	CcSEcCtD
Ceftriaxone—Nausea—Simvastatin—atherosclerosis	0.000308	0.00212	CcSEcCtD
Ceftriaxone—Vomiting—Niacin—atherosclerosis	0.000303	0.00209	CcSEcCtD
Ceftriaxone—Rash—Niacin—atherosclerosis	0.0003	0.00207	CcSEcCtD
Ceftriaxone—Dermatitis—Niacin—atherosclerosis	0.0003	0.00207	CcSEcCtD
Ceftriaxone—Headache—Niacin—atherosclerosis	0.000298	0.00206	CcSEcCtD
Ceftriaxone—Vomiting—Pravastatin—atherosclerosis	0.000298	0.00206	CcSEcCtD
Ceftriaxone—Rash—Pravastatin—atherosclerosis	0.000296	0.00204	CcSEcCtD
Ceftriaxone—Dermatitis—Pravastatin—atherosclerosis	0.000295	0.00204	CcSEcCtD
Ceftriaxone—Headache—Pravastatin—atherosclerosis	0.000294	0.00202	CcSEcCtD
Ceftriaxone—Nausea—Niacin—atherosclerosis	0.000283	0.00195	CcSEcCtD
Ceftriaxone—Nausea—Pravastatin—atherosclerosis	0.000278	0.00192	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—atherosclerosis	0.000207	0.0532	CrCbGaD
Ceftriaxone—Cefazolin—ALB—atherosclerosis	0.00017	0.0437	CrCbGaD
Ceftriaxone—Cefalotin—ALB—atherosclerosis	0.000141	0.0363	CrCbGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—TRPV1—atherosclerosis	8.65e-05	0.00143	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—INS—atherosclerosis	8.56e-05	0.00141	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—atherosclerosis	8.55e-05	0.00141	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—MTHFR—atherosclerosis	8.55e-05	0.00141	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—PLAT—atherosclerosis	8.54e-05	0.00141	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—APOA1—atherosclerosis	8.49e-05	0.0014	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	8.47e-05	0.0014	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—CCL2—atherosclerosis	8.42e-05	0.00139	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ABCG5—atherosclerosis	8.33e-05	0.00137	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—CETP—atherosclerosis	8.31e-05	0.00137	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—HMGCR—atherosclerosis	8.24e-05	0.00136	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CRP—atherosclerosis	8.13e-05	0.00134	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—atherosclerosis	8.09e-05	0.00133	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—OLR1—atherosclerosis	8.06e-05	0.00133	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—ALB—atherosclerosis	7.92e-05	0.00131	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.89e-05	0.0013	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—APOA1—atherosclerosis	7.86e-05	0.0013	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—SERPINE1—atherosclerosis	7.86e-05	0.0013	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL1B—atherosclerosis	7.85e-05	0.00129	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—F2—atherosclerosis	7.5e-05	0.00124	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—ICAM1—atherosclerosis	7.47e-05	0.00123	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VWF—atherosclerosis	7.45e-05	0.00123	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—CETP—atherosclerosis	7.39e-05	0.00122	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ABCA1—atherosclerosis	7.34e-05	0.00121	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	7.34e-05	0.00121	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	7.34e-05	0.00121	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	7.32e-05	0.00121	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—NFKB1—atherosclerosis	7.32e-05	0.00121	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	7.31e-05	0.00121	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG4—atherosclerosis	7.28e-05	0.0012	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—PLG—atherosclerosis	7.26e-05	0.0012	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IFNG—atherosclerosis	7.16e-05	0.00118	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—IGF1—atherosclerosis	7.09e-05	0.00117	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG8—atherosclerosis	6.98e-05	0.00115	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—INS—atherosclerosis	6.8e-05	0.00112	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.79e-05	0.00112	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—atherosclerosis	6.76e-05	0.00111	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—SERPINE1—atherosclerosis	6.74e-05	0.00111	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—PLG—atherosclerosis	6.71e-05	0.00111	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—HMOX1—atherosclerosis	6.7e-05	0.0011	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CCL2—atherosclerosis	6.69e-05	0.0011	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.51e-05	0.00107	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—atherosclerosis	6.42e-05	0.00106	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—APOB—atherosclerosis	6.42e-05	0.00106	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL1B—atherosclerosis	6.38e-05	0.00105	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINC1—atherosclerosis	6.37e-05	0.00105	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—HMOX1—atherosclerosis	6.3e-05	0.00104	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—SERPINE1—atherosclerosis	6.24e-05	0.00103	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—PLG—atherosclerosis	6.22e-05	0.00103	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	6.19e-05	0.00102	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—CETP—atherosclerosis	6.17e-05	0.00102	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—ALB—atherosclerosis	6.04e-05	0.000996	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOB—atherosclerosis	6.04e-05	0.000995	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—NFKB1—atherosclerosis	5.96e-05	0.000982	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOB—atherosclerosis	5.93e-05	0.000978	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTM1—atherosclerosis	5.87e-05	0.000968	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	5.8e-05	0.000957	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—LPL—atherosclerosis	5.76e-05	0.00095	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.74e-05	0.000947	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—atherosclerosis	5.69e-05	0.000939	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IFNG—atherosclerosis	5.69e-05	0.000938	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GPX1—atherosclerosis	5.62e-05	0.000927	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—KNG1—atherosclerosis	5.56e-05	0.000916	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PLG—atherosclerosis	5.54e-05	0.000913	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG1—atherosclerosis	5.52e-05	0.00091	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOB—atherosclerosis	5.5e-05	0.000907	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CD36—atherosclerosis	5.48e-05	0.000903	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	5.46e-05	0.0009	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	5.46e-05	0.0009	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—atherosclerosis	5.45e-05	0.000899	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.43e-05	0.000896	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.41e-05	0.000893	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PLG—atherosclerosis	5.38e-05	0.000888	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	5.36e-05	0.000883	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F3—atherosclerosis	5.34e-05	0.000881	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	5.26e-05	0.000868	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—MTHFR—atherosclerosis	5.19e-05	0.000856	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SOD1—atherosclerosis	5.16e-05	0.000851	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.11e-05	0.000843	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARA—atherosclerosis	5.09e-05	0.00084	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.08e-05	0.000837	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL1B—atherosclerosis	5.07e-05	0.000836	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F5—atherosclerosis	5.06e-05	0.000835	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SELP—atherosclerosis	5.06e-05	0.000835	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—atherosclerosis	5.04e-05	0.000831	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	5e-05	0.000825	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	5e-05	0.000825	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AGT—atherosclerosis	4.93e-05	0.000813	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF2—atherosclerosis	4.9e-05	0.000808	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOB—atherosclerosis	4.89e-05	0.000807	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.86e-05	0.000802	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CLU—atherosclerosis	4.83e-05	0.000797	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOE—atherosclerosis	4.83e-05	0.000797	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CAV1—atherosclerosis	4.79e-05	0.000789	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOA1—atherosclerosis	4.78e-05	0.000788	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	4.77e-05	0.000787	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—NFKB1—atherosclerosis	4.73e-05	0.00078	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.69e-05	0.000774	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.64e-05	0.000765	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—atherosclerosis	4.63e-05	0.000764	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—atherosclerosis	4.63e-05	0.000764	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	4.62e-05	0.000762	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	4.61e-05	0.00076	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	4.61e-05	0.00076	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	4.61e-05	0.00076	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	4.61e-05	0.00076	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—atherosclerosis	4.59e-05	0.000758	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.55e-05	0.000751	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—THBD—atherosclerosis	4.54e-05	0.000749	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—TRPV1—atherosclerosis	4.5e-05	0.000742	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	4.42e-05	0.000729	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—atherosclerosis	4.41e-05	0.000728	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.4e-05	0.000725	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CG—atherosclerosis	4.36e-05	0.000719	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.35e-05	0.000718	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—ABCG5—atherosclerosis	4.33e-05	0.000714	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—CD36—atherosclerosis	4.32e-05	0.000712	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SELE—atherosclerosis	4.31e-05	0.00071	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.26e-05	0.000703	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TGFB1—atherosclerosis	4.25e-05	0.000701	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.22e-05	0.000695	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARG—atherosclerosis	4.21e-05	0.000694	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.13e-05	0.000681	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—INS—atherosclerosis	4.13e-05	0.000681	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	4.08e-05	0.000674	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.06e-05	0.000669	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—atherosclerosis	4.05e-05	0.000668	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—atherosclerosis	4.02e-05	0.000663	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LDLRAP1—atherosclerosis	4.01e-05	0.000661	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	3.98e-05	0.000657	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.92e-05	0.000646	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.87e-05	0.000639	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VWF—atherosclerosis	3.84e-05	0.000633	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—atherosclerosis	3.78e-05	0.000624	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLTP—atherosclerosis	3.77e-05	0.000622	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	3.76e-05	0.000621	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—atherosclerosis	3.74e-05	0.000617	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.72e-05	0.000613	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	3.68e-05	0.000607	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F7—atherosclerosis	3.66e-05	0.000604	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—atherosclerosis	3.62e-05	0.000597	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	3.59e-05	0.000592	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.49e-05	0.000576	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.47e-05	0.000573	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.45e-05	0.000569	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.45e-05	0.000569	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.45e-05	0.000568	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	3.44e-05	0.000567	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.37e-05	0.000556	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—atherosclerosis	3.31e-05	0.000546	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG8—atherosclerosis	3.27e-05	0.000539	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LTA4H—atherosclerosis	3.27e-05	0.000539	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAT—atherosclerosis	3.26e-05	0.000538	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.23e-05	0.000533	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.23e-05	0.000532	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	3.21e-05	0.000529	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	3.15e-05	0.000519	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	3.07e-05	0.000506	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.05e-05	0.000503	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	2.99e-05	0.000493	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	2.97e-05	0.00049	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KNG1—atherosclerosis	2.86e-05	0.000472	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAUR—atherosclerosis	2.84e-05	0.000468	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.82e-05	0.000466	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLG—atherosclerosis	2.77e-05	0.000458	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.72e-05	0.000448	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SOD1—atherosclerosis	2.66e-05	0.000439	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG1—atherosclerosis	2.58e-05	0.000426	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	2.56e-05	0.000422	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF2—atherosclerosis	2.53e-05	0.000417	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOB—atherosclerosis	2.45e-05	0.000404	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LCAT—atherosclerosis	2.43e-05	0.000401	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FABP4—atherosclerosis	2.43e-05	0.000401	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	2.4e-05	0.000396	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA4—atherosclerosis	2.39e-05	0.000393	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP7A1—atherosclerosis	2.34e-05	0.000386	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCG—atherosclerosis	2.28e-05	0.000376	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.23e-05	0.000368	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD36—atherosclerosis	2.23e-05	0.000367	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.22e-05	0.000366	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP27A1—atherosclerosis	2.17e-05	0.000357	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.13e-05	0.000352	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	2.12e-05	0.00035	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.08e-05	0.000343	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	2.06e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA2—atherosclerosis	2.05e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G2A—atherosclerosis	2.05e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALOX5AP—atherosclerosis	2.05e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALOX15—atherosclerosis	2.05e-05	0.000339	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PDGFB—atherosclerosis	2.05e-05	0.000338	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MMP1—atherosclerosis	2.03e-05	0.000335	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCG5—atherosclerosis	2.03e-05	0.000334	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.03e-05	0.000334	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPA—atherosclerosis	1.96e-05	0.000323	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CAV1—atherosclerosis	1.95e-05	0.000321	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.94e-05	0.000321	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOA1—atherosclerosis	1.94e-05	0.00032	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BGN—atherosclerosis	1.9e-05	0.000313	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.89e-05	0.000311	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.88e-05	0.000311	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA5—atherosclerosis	1.88e-05	0.00031	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F2—atherosclerosis	1.85e-05	0.000305	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS2—atherosclerosis	1.83e-05	0.000302	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.82e-05	0.000301	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLA2G1B—atherosclerosis	1.81e-05	0.000298	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.79e-05	0.000295	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.79e-05	0.000295	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CG—atherosclerosis	1.77e-05	0.000292	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.77e-05	0.000292	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.77e-05	0.000291	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALOX5—atherosclerosis	1.75e-05	0.000288	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.68e-05	0.000277	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKT1—atherosclerosis	1.66e-05	0.000274	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IGF1—atherosclerosis	1.62e-05	0.000268	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.61e-05	0.000266	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NAMPT—atherosclerosis	1.57e-05	0.000258	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.56e-05	0.000257	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LIPC—atherosclerosis	1.56e-05	0.000257	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOC3—atherosclerosis	1.55e-05	0.000255	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINE1—atherosclerosis	1.54e-05	0.000254	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LDLR—atherosclerosis	1.54e-05	0.000253	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CETP—atherosclerosis	1.5e-05	0.000248	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—atherosclerosis	1.47e-05	0.000243	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SCARB1—atherosclerosis	1.44e-05	0.000237	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMGCR—atherosclerosis	1.36e-05	0.000224	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.31e-05	0.000216	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.22e-05	0.000202	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ABCA1—atherosclerosis	1.21e-05	0.0002	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—atherosclerosis	1.06e-05	0.000175	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—atherosclerosis	1.04e-05	0.000171	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK3—atherosclerosis	1e-05	0.000165	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOB—atherosclerosis	9.94e-06	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB1—atherosclerosis	9.73e-06	0.00016	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM1—atherosclerosis	9.67e-06	0.00016	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—LPL—atherosclerosis	9.5e-06	0.000157	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPX1—atherosclerosis	9.26e-06	0.000153	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CD36—atherosclerosis	9.02e-06	0.000149	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTHFR—atherosclerosis	8.55e-06	0.000141	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARA—atherosclerosis	8.39e-06	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AGT—atherosclerosis	8.12e-06	0.000134	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—atherosclerosis	7.96e-06	0.000131	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAV1—atherosclerosis	7.89e-06	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA1—atherosclerosis	7.87e-06	0.00013	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CG—atherosclerosis	7.18e-06	0.000118	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARG—atherosclerosis	6.93e-06	0.000114	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—INS—atherosclerosis	6.8e-06	0.000112	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—AKT1—atherosclerosis	6.76e-06	0.000111	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—atherosclerosis	5.96e-06	9.83e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—atherosclerosis	5.45e-06	8.99e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKT1—atherosclerosis	2.74e-06	4.52e-05	CbGpPWpGaD
